Company intelligence / Profile preview

WayBetter

Ownership: Private
Development stage: Other

Overview

WayBetter has demonstrated effectiveness in supporting healthy behavior changes through its gamified apps. For example, a clinical trial of the QuitBet app showed that 40% of participants quit smoking for four weeks using the program's combination of financial incentives, social support, and biometric feedback from CO monitoring devices. The company’s approach is grounded in peer-reviewed behavioral science research and has received recognition at major scientific conferences such as the Society of Behavioral Medicine annual meeting

Therapeutic areas: PsychiatryEndocrinologyMetabolic Disorders
Modalities: Non-pharmacological therapyDevice
Industry: Digital Health Medical Devices

Partnerships

Bedfont Scientific LimitedU.S. National Institutes of Health

Beyond the preview

Go deeper on WayBetter.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WayBetter.

Explore the full profile